Roche provides molecular testing solutions to identify and differentiate SARS-CoV-2 Omicron variants of concern
The Pharma Data
MARCH 16, 2022
It’s critical to quickly and accurately identify variants to inform ongoing research – including the ongoing development of therapeutics and vaccines. To support customers performing human genotyping, TIB Molbiol provides custom-made LightSNiP assays for SNP analysis. 2, as well as other mutations, present in the novel B.1.1.529
52 
Let's personalize your content